Q-Med (QMED)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

Sk 46.00
   
  • 52 Week High: Sk47.90
  • 52 Week Low: Sk23.20
  • Currency: Swedish Krona
  • Shares Issued: 99.38m
  • Market Cap: Sk4,571.57m

Q-Med Overview

Q-Med is a biotechnology company that develops, manufactures and sells medical implants. The Company holds patented technology NASHA (Non-Animal Stabilized Hyaluronic Acid), and engages in research and development of new treatment techniques and innovative products.

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 3.9%
ROCE 4.8%
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue -3.5%
PBT -83.3%
EPS -89.3%
DPS n/a

Q-Med Fundamentals

Year Ending Revenue (Skm) Pre-tax (Skm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-04 823.23 361.80 0.68Sk 67.8 n/a -68% 0.19 0.4%
31-Dec-05 976.01 123.97 0.19Sk 321.2 n/a -71% 0.19 0.3%
31-Dec-06 1,227.65 308.02 2.14Sk 49.9 0.1 +997% 1.00 0.9%
31-Dec-07 1,317.63 369.81 3.17Sk 26.5 0.6 +48% 1.50 1.8%
31-Dec-08 1,271.88 61.90 0.34Sk 71.8 n/a -89% n/a 0.0%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

Q-Med Market Data

Currency Swedish Krona
% Change 5.26 %
52 Week High Sk47.90
52 Week Low Sk23.20
Shares Issued 99.38m
Market Cap Sk4,571.57m

Top of Page